In vitro study of using calcium phosphate cement as immunoisolative device to enclose insulinoma/agarose microspheres as bioartificial pancreas

Biotechnology and Bioengineering

Volumn 98, Issue 6, 2007, Pages 1288-1295

  Yang, Kai Chiang ^a   Yang, Ching Yao ^b   Wu, Chang Chin ^a,c   Kuo, Tzong Fu ^d   Lin, Feng Huei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Calcium phosphate cement; Cell therapy; Encapsulation; Immunoisolation

Indexed keywords

CALCIUM PHOSPHATE; CYTOTOXICITY; MOLECULAR WEIGHT; POROSIMETERS; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BIOARTIFICIAL PANCREAS; CALCIUM PHOSPHATE CEMENT; CELL THERAPY; IMMUNOISOLATION;

BONE CEMENT;

AGAROSE; BETA GALACTOSIDASE; CALCIUM PHOSPHATE CERAMIC;

ARTICLE; BIOARTIFICIAL ORGAN; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; INSULINOMA; MOLECULAR WEIGHT; POROSITY; SCANNING ELECTROCHEMICAL MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; BIOMECHANICS; CALCIUM PHOSPHATES; CELL LINE; EQUIPMENT DESIGN; FEASIBILITY STUDIES; INSULIN; INSULINOMA; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PANCREAS, ARTIFICIAL; RATS; SEPHAROSE;

EID: 36749022221     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21506     Document Type: Article

References (34)

1. Calne R. 2005. Clinical transplantation: Current problems, possible solutions. Philos Trans R Soc Lond B Biol Sci 360(1461):1797-1801.
2. Carlsson PO, Liss P, Andersson A, Jansson L. 1998. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 47(7):1027-1032.
3. Carlsson PO, Palm F, Andersson A, Liss P. 2001. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50(3):489-495.
4. Chen WC, Lin CJH, Ju CP. 2003. Transmission electron microscopic study on setting mechanism of tetracalcium phosphate/dicalcium phosphate anhydrous-based calcium phosphate cement. J Biomed Mater Res 64(4):664-671.
5. Colton CK. 1995. Implantable biohybrid artificial organs. Cell Transplant 4(4):415-436.
6. de Groot M, Schuurs TA, Leuvenink HG, van Schilfgaarde R. 2003. Macrophage overgrowth affects neighboring nonovergrown encapsulated islets. J Surg Res 115(2):235-241.
7. de Groot M, Schuurs TA, van Schilfgaarde R. 2004. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 121(1):141-150.
8. de Vos P, de Haan B, Pater J, Van Schilfgaarde R. 1996. Association between capsule diameter, adequacy of encapsulation and survival of micro-encapsulated rat islet allograft. Transplantation 62(7):893-899.
9. de Vos P, Van Straaten JF, Nieuwenhuizen AG, de Groot M, Ploeg RJ, de Haan BJ, Van Schilfgaarde R. 1999. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48(7):1381-1388.
10. de Vos P, Hamel AF, Tatarkiewicz K. 2002. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45(2):159-173.
11. Edge AS, Gosse ME, Dinsmore J. 1998. Xenogeneic cell therapy: Current progress and future developments in porcine cell transplantation. Cell Transplantation 7(6):525-539.
12. Galandiuk S, Sterioff S. 2005. The problems of organ donor shortage. Mayo Clin Proc 80:320-321.
13. Gisep A, Wieling R, Bohner M, Matter S, Schneider E, Rahn B. 2003. Resorption patterns of calcium-phosphate cements in bone. J Biomed Mater Res 66(3):532-540.
14. Hamaguchi K, Utsunomiya N, Takaki R, Yoshimatsu H, Sakata T. 2003. Cellular interaction between mouse pancreatic alpha-cell and beta-cell lines: Possible contact-dependent inhibition of insulin secretion. Exp Biol Med (Maywood) 228(10):1227-1233.
15. Harrison JS, Rameshwar P, Chang V, Bandari P. 2002. Oxygen saturation in the bone marrow of healthy volunteers. Blood 99(1):394.
16. Hideki A. 1994. Medical applications of hydroxyapatite. Tokyo: Ishiyaku EuroAmerica. p 225.
17. Ishikawa K, Takagi S, Chow LC, Suzuki K. 1999. Reaction of calcium phosphate cements with different amounts of tetracalcium phosphate and dicalcium phosphate anhydrous. J Biomed Mater Res 46(4):504-510.
18. Karen JLB, Scott P, James FK. 2000. Biomaterial developments for bone tissue engineering. Biomaterials 21(23):2347-2359.
19. Kurashina K, Kurita H, Kotani A, Takeuchi H, Himno M. 1997. In vivo study of a calcium phosphate cement consisting of α-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide. Biomaterials 18:147-151.
20. Li RH. 1998. Materials for immunoisolated cell transplantation. Adv Drug Deliv Rev 33(1-2):87-109.
21. Lin FH. 2002. Tissue engineering of pancreas. J Genet Mol Biol 13(2):145.
22. Liu CS, Shen W, Gu YF, Hu LM. 1997. Mechanism of the hardening process for a hydroxyapatite cement. J Biomed Mater Res 35(1):75-80.
23. Lu JX, Gallur A, Flautre B, Anselme K, Descamps M, Thierry B, Hardouin P. 1998. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res 42(3):357-367.
24. Merani S, Shapiro AM. 2006. Current status of pancreatic islet transplantation. Clin Sci 110(6):611-625.
25. Mikos AG, Papadaki MG, Kouvroukoglou S, Ishaug SL, Thomson RC. 1994. Mini review: Islet transplantation to create a bioartificial pancreas. Biotechnol Bioeng 43(7):673-677.
26. Narang AS, Mahato RI. 2006. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev 58(2):194-243.
27. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV. 1996. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab 81(9):3197-3202.
28. Rihova B. 2000. Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev 42(1-2):65-80.
29. Robert PL, Robert L, Joseph V. 2000. Principles of tissue engineering. San Diego: Academic Press. p. 331.
30. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM. 2001. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50(4):710-719.
31. Sigrist S, Ebel N, Langlois A, Bosco D, Toso C, Kleiss C, Mandes K, Berney T, Pinget M, Belcourt A, Kessler L. 2005. Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation. Transplant Proc 37(8):3516-3518.
32. Tomoaki U, Junji W, Kazuhiko I. 2002. Biocompatible polymer alloy membrane for implantable artificial pancreas. J Membr Sci 208(1):39-48.
33. Vial T, Descotes J. 2003. Immunosuppressive drugs and cancer. Toxicology 185(3):229-240.
34. Willem MK, Robert PL, William LC. 1999. Cell encapsulation technology and therapeutics. Boston: Birkhauser. p 29.